Frontiers in Radiation Fractionation in Radiation Therapy: Theoretical Basis, Experimental, and Clinical Studies

References

• Del Regato J A. Historical changes in time-dose relationship in therapeutic radiology. Front Rad Ther Oncol 1968; 3: 1–5
   Google Scholar
• Strandqvist M. Studien über die Kumulative Wirkung der Röntgenstrahlen bei Fraktionierung. Erfahrungen aus dem Radiumhemmet an 280 Haut und Lippen Karsinomen. Acta Radiol Suppl 1944; 55: 1–300
   Google Scholar
• Ellis F. Fractionation in radiotherapy. Modern Trends in Radiotherapy, T J Deeley, C AP Wood. Butterworth, London 1967; Vol 1: 34–51
   Google Scholar
• Orton C G, Ellis F. A simplication of the use of the NSD concept in practical radiotherapy. Br J Radiol 1973; 46: 529–537
   PubMed Web of Science ®Google Scholar
• Kirk J, Gray W M, Watson R. Cumulative radiation effect, Part I: Fractionated treatment regimes. Clin Radiol 1971; 22: 145–155
   PubMedGoogle Scholar
• Cohen L, Creditor M. Iso-effect tables for tolerance of irradiated normal human tissues. Int J Rad Oncol Biol Phys 1983; 9: 233–241
   PubMed Web of Science ®Google Scholar
• Fowler J. Proceedings of the Conference on Time-Dose Relationships in Clinical Radiotherapy, W L Caldwell, D D Tolbert. Madison Printing and Publishing Co, Middleton, WI 1974; 13–26
   Google Scholar
• Douglas B G, Fowler J R. Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol (Letter) 1975; 48: 502–504
   PubMed Web of Science ®Google Scholar
• Barendsen G W. Dose fractionation, dose rate, and isoeffect relationships for normal tissue responses. Int J Rad Oncol Biol Phys 1982; 8: 1981–1997
   PubMed Web of Science ®Google Scholar
• Fowler J F. Non-standard fractionation in radiation therapy. Non-published refresher course. Am Soc Ther Rad Mtg. Orlando, FL 1982
   Google Scholar
• Thames H D, Withers H R, Peters L J, et al. Changes in early and late radiation responses with altered dose fractionation: Implications for dose—survival relationships. Int J Rad Oncol Biol Phys 1982; 8: 219–226
   PubMed Web of Science ®Google Scholar
• Thames H D, Peters L J, Withers H R, et al. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day. Int J Rad Oncol Biol Phys 1983; 9: 127–138
   PubMed Web of Science ®Google Scholar
• Douglas B G. Superfractionation: its rationale and anticipated benefits. Int J Rad Oncol Biol Phys 1982; 8: 1143–1153
   PubMed Web of Science ®Google Scholar
• Withers H R. The four R's of radiotherapy. Adv Rad Biol 1975; 5: 241–271
   Google Scholar
• Kallman R F. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology 1972; 105: 135–142
   PubMed Web of Science ®Google Scholar
• Arcangeli G, Mauro F, Morelli D, et al. Multiple daily fractionation in radiotherapy: Biological rationale and preliminary clinical experiences. Eur J Cancer 1979; 15: 1077–1083
   PubMed Web of Science ®Google Scholar
• Fertil B, Malaise E-P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Rad Oncol Biol Phys 1981; 7: 621–629
   PubMed Web of Science ®Google Scholar
• Wideröe R. Investigations on fractionation schemes. Strahlentherapie 1974; 148: 46–52
   PubMedGoogle Scholar
• McNally N J. Fractionated radiotherapy of tumour cells possessing wide-shouldered survival curves and capable of reoxygenation. Br J Radiol 1980; 53: 703–706
   PubMed Web of Science ®Google Scholar
• Suit M D, Howes A E, Hunter N. Dependence of response of a C3H mammary carcinoma to fractionated irradiation on fractionation number and intertreatment interval. Radiat Res 1977; 72: 440–454
   PubMed Web of Science ®Google Scholar
• Wheldon T E, Kirk J. Mathematical derivation of optimal treatment schedules for the radiotherapy of human tumours. Fractionated irradiation of exponentially growing tumours. Br J Radiol 1976; 49: 441–449
   PubMed Web of Science ®Google Scholar
• Wheldon T E. Optimal fractionation for the radiotherapy of tumour cells possessing wide-shouldered survival curves. Br J Radiol 1979; 52: 417–418
   PubMed Web of Science ®Google Scholar
• Phillips T L. Split-dose recovery in anoxic and hypoxic normal and tumor cells. Radiology 1972; 105: 127–134
   PubMed Web of Science ®Google Scholar
• Probert J C, Brown J M. A comparison of three and five times weekly fractionation on the response of normal and malignant tissues of the C3H mouse. Br J Radiol 1974; 47: 775–780
   PubMed Web of Science ®Google Scholar
• Kim J H, Chu F CH, Hilaris B. The influence of dose fractionation on acute and late reactions in patients with postoperative radiotherapy for carcinoma of the breast. Cancer 1975; 35: 1583–1586
   PubMed Web of Science ®Google Scholar
• Jakobsson PÅ, Littbrand B. Fractionation schemes with low individual tumour dose and high total dose. Acta Radiol Ther Phys Biol 1973; 12: 337–346
   PubMed Web of Science ®Google Scholar
• Choi C H, Suit H D. Evaluation of rapid radiation treatment schedules utilizing two treatment sessions per day. Radiology 1975; 116: 703–707
   PubMed Web of Science ®Google Scholar
• Arcangeli G, Mauro F, Nervi C, et al. Dose—survival relationship for epithelial cells of human skin after multifraction irradiation: Evaluation by a quantitative method in vivo. Int J Rad Oncol Biol Phys 1980; 6: 841–844
   PubMed Web of Science ®Google Scholar
• Wara W M, Phillips T L, Margolis L W, et al. Radiation pneumonitis: A new approach to the derivation of time-dose factors. Cancer 1973; 32: 547–552
   PubMed Web of Science ®Google Scholar
• Wara W M, Phillips T L, Sheline G E, et al. Radiation tolerance of the spinal cord. Cancer 1975; 35: 1558–1562
   PubMed Web of Science ®Google Scholar
• Dutreix J. Current techniques in the use of nonstandard fractionation. High Energy Photons and Electrons: Clinical Applications in Cancer Management, S Kramer, N Suntharalingam, G F Zinninger. John Wiley and Sons, New York 1979; 116–128
   Google Scholar
• Wiernik G, Bleehen N M, Brindle J, et al. Sixth interim progress report of the British Institute of Radiology fractionation study of 3 F/week versus 5 F/week in radiotherapy of the laryngo-pharynx. Br J Radiol 1978; 51: 241–250
   PubMed Web of Science ®Google Scholar
• D'urkovsk J, Ševčíková L, Miklánková M. Results of radiotherapy of carcinoma laryngis in relation to the mode of dose fractionation. Neoplasm 1981; 28: 599–609
   PubMed Web of Science ®Google Scholar
• Eichorn H J. Different fractionation schemes tested by histological examination of autopsy specimens from lung cancer patients. Br J Radiol 1981; 54: 132–135
   PubMed Web of Science ®Google Scholar
• Habermalz H J, Fischer J J. Radiation therapy of malignant melanoma: experience with high individual treatment doses. Cancer 1976; 38: 2258–2262
   PubMed Web of Science ®Google Scholar
• Strauss A, Dritschilo A, Nathanson L, et al. Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemes. Cancer 1981; 47: 1262–1266
   PubMed Web of Science ®Google Scholar
• Katz H R. The results of different fractionation schemes in the palliative irradiation of metastatic melanoma. Int J Rad Oncol Biol Phys 1981; 7: 907–911
   PubMed Web of Science ®Google Scholar
• Hornsey S. The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma patients. Br J Radiol 1978; 51: 905–909
   PubMed Web of Science ®Google Scholar
• Kim J H, Nisce L Z, D'Angio G J. Dose-time fractionation study in patients with mycosis fungoides and lymphoma cutis. Radiology 1976; 119: 439–442
   PubMed Web of Science ®Google Scholar
• Baclesse F. Five year results in 431 breast cancers treated solely by roentgen rays. Ann Surg 1965; 161: 103–104
   PubMed Web of Science ®Google Scholar
• Montague E. Radiotherapy as primary modality in treatment of curable breast cancer. The Breast, H S Gallager, H P Leis, R K Snyderman, J A Urban. CV Mosby, St Louis 1978; 271–283
   Google Scholar
• Notter G, Turesson I. Prospective studies with the CRE formula of prolonged fractionation schedules. Radiology 1976; 121: 709–715
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Rouby E, Kramer S. Results of a pilot study with extended fractionation in the treatment of lung cancer. Int J Rad Oncol Biol Phys 1979; 5: 2039–2042
   PubMed Web of Science ®Google Scholar
• Bäckström A, Jakobsson PÅ, Littbrand B, et al. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta Radiol Ther Phys Biol 1973; 12: 401–406
   PubMedGoogle Scholar
• Shukovsky L J, Fletcher G H, Montague E D, et al. Experience with twice-a-day fractionation in clinical radiotherapy. Am J Roentgenol 1976; 126: 155–162
   PubMed Web of Science ®Google Scholar
• Jampolis A, Pipard G, Horiot J-C, et al. Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck. Am J Roentgenol 1977; 129: 1091–1093
   PubMed Web of Science ®Google Scholar
• Medini E, Rao Y, Kim T, et al. Radiation therapy for advanced head and neck squamous-cell carcinoma using twice-a-day fractionation. Radiology 1980; 134: 531–532
   PubMed Web of Science ®Google Scholar
• Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Rad Oncol Biol Phys 1981; 7: 99–104
   PubMed Web of Science ®Google Scholar
• Van den Bogaert W, van der Schueren E, Horiot J-C, et al. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. Int J Rad Oncol Biol Phys 1982; 8: 1649–1655
   PubMed Web of Science ®Google Scholar
• Van den Bogaert W, van der Schueren E. Critique of Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experience. Int J Rad Oncol Biol Phys (Letter) 1981; 7: 1133–1134
   PubMed Web of Science ®Google Scholar
• Edsmyr F, Esposti P L, Giertz G, et al. Radiation treatment of urinary bladder carcinoma. Urol Res 1978; 6: 229–232
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, McDay J, Leeper D, et al. Optimum fractionation for irradiation of carcinoma of the bladder—Experiments based on one case. Acta Radiol Oncol 1979; 18: 11–16
   Google Scholar
• Richie J P, Weichselbaum R, Greenberger J, et al. Twice-a-day fractionation preoperative radiotherapy in patients with carcinoma of the bladder: preliminary report. J. Urol 1981; 125: 179–181
   PubMed Web of Science ®Google Scholar
• Ang K K, van der Schueren E. The tolerance to multiple daily fractionated radiotherapy for the treatment of prostatic and bladder carcinoma: a feasibility study. Int J Rad Oncol Biol Phys 1982; 8: 1665–1670
   PubMed Web of Science ®Google Scholar
• Douglas B G. Preliminary results using superfractionation in the treatment of glioblastoma multiforme. J Can Assoc Radiol 1977; 28: 106–110
   PubMedGoogle Scholar
• Ang K K, van der Scheuren E, Notter G, et al. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas. Int J Rad Oncol Biol Phys 1982; 8: 1657–1664
   PubMed Web of Science ®Google Scholar
• Simpson W J, Platts M E. Fractionation study in the treatment of glioblastoma multiforme. Int J Rad Oncol Biol Phys 1976; 1: 639–644
   PubMed Web of Science ®Google Scholar
• Svoboda V HJ. Further experience with radiotherapy by multiple daily sessions. Br J Radiol 1978; 51: 363–369
   PubMed Web of Science ®Google Scholar
• Norin T, Einhorn C J, Einhorn N, et al. Conventional and superfractionated radiation therapy in Burkitt's lymphoma. Acta Radiol Ther Phys Biol 1971; 10: 545–557
   PubMed Web of Science ®Google Scholar
• Norin T, Onyango J. Radiotherapy in Burkitt's lymphoma: Conventional or superfractionated regimen—early results. Int J Rad Oncol Biol Phys 1977; 2: 399–406
   PubMed Web of Science ®Google Scholar
• Norin T. Radiation therapy in Burkitt's lymphoma of the central nervous system: Primary results. Acta Radiol Ther Phys Biol 1977; 16: 73–80
   PubMed Web of Science ®Google Scholar
• Suit H D. Superfractionation. Int J Rad Oncol Biol Phys 1977; 2: 591–592
   PubMed Web of Science ®Google Scholar
• Peters L J, Withers H R, Cundiff J H, Dicke K A. Radiobiological considerations in the use of total-body irradiation for bone marrow transplantation. Radiology 1979; 131: 243–247
   PubMed Web of Science ®Google Scholar
• Peters L. Discussion: The radiobiological bases of TBI. Int J Rad Oncol Biol Phys 1980; 6: 785–787
   PubMed Web of Science ®Google Scholar
• Song C W, Kim T H, Khan F M, Kersey J H, Levitt S H. Radiobiological basis of total body irradiation with different dose rate and fractionation: repair capacity of hemopoietic cells. Int J Rad Oncol Biol Phys 1981; 7: 1695–1701
   PubMed Web of Science ®Google Scholar
• Evans R G. Radiobiological considerations in macro-field irradiation. Int J Rad Oncol Biol Phys, in press
   Web of Science ®Google Scholar
• Rubin P, Scarantino C W. Bone marrow repopulation—Fractionated vs single dose effects (abstract). Rad Res Soc Abst, 25th Annual Mtg. 1977
   Google Scholar
• Hagenbeek A, Martens A CM. The effect of fractionated versus unfractionated total body irradiation on the growth of the BN acute myelocytic leukemia. Int J Rad Oncol Biol Phys 1981; 7: 1075–1079
   PubMed Web of Science ®Google Scholar
• Dutreix J, Wambersie A, Loirette M, et al. Time factors in total body irradiation. Pathol Biol 1979; 27: 365–369
   PubMed Web of Science ®Google Scholar
• Kolb H J, Rieder I, Bodenberger U, et al. Dose rate and dose fractionation studies in total body irradiation of dogs. Pathol Biol 1979; 27: 370–372
   PubMed Web of Science ®Google Scholar
• Deeg H J, Storb R, Weiden P L, et al. High-dose total-body irradiation and autologous marrow reconstitution in dogs: Dose-rate-related acute toxicity and fractionation-dependent long-term survival. Radiat Res 1981; 88: 385–391
   PubMed Web of Science ®Google Scholar
• Lichter A S, Tracy D, Lam W-C, et al. Total body irradiation in bone marrow transplantation: The influence of fractionation and delay of marrow infusion. Int J Rad Oncol Biol Phys 1980; 6: 301–309
   PubMed Web of Science ®Google Scholar
• Loeffler R K. Therapeutic use of fractionated total body and subtotal body irradiation. Cancer 1981; 47: 2253–2258
   PubMed Web of Science ®Google Scholar
• UCLA Bone Marrow Transplant Team. A phase-II trial of fractionated total body radiation in bone marrow transplantation for acute leukemia. Transplant Proc 1979; 11: 205–207
   PubMed Web of Science ®Google Scholar
• Lichter A S, Tutschka P J, Wharam M D, et al. The use of fractionated radiotherapy as preparation for allogeneic bone marrow transplantation. Transplant Proc 1979; 11: 1492–1494
   PubMed Web of Science ®Google Scholar
• Thomas E D, Clift R A, Hersman J, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int J Rad Oncol Biol Phys 1982; 8: 817–821
   PubMed Web of Science ®Google Scholar
• Buckner C D, Clift R A, Thomas E D, et al. Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. Leuk Res 1982; 6: 395–399
   PubMed Web of Science ®Google Scholar
• Shank B, Simpson L. The Bone Marrow Transplant Team: The role of total body irradiation in bone marrow transplantation for leukemia. Bull NY Acad Med 1982; 58: 763–777
   PubMedGoogle Scholar
• Pino Y, Torres J L, Bross D S, Lam W-C, et al. Risk factors in interstitial pneumonitis following allogenic bone marrow transplantation. Int J Rad Oncol Biol Phys 1982; 8: 1301–1307
   PubMed Web of Science ®Google Scholar